Who needs direct-acting antivirals for HCV? Challenges faced in advancing HCV therapy for HIV–HCV-coinfected individuals
Describing the characteristics of coinfected patients who could be eligible for direct-acting antivirals
View PublicationFiltrer par:
Antiretroviral treatment interruption leads to progression of liver fibrosis in HIV–hepatitis C virus co-infection
Examining the impact of ART interruption on liver fibrosis progression in co-infected adults
View PublicationPolymorphism in tumor necrosis factor-related apoptosis-inducing ligand receptor 1 is associated with poor viral response to interferon-based hepatitis C virus therapy in HIV/hepatitis C virus-coinfected individuals
Investigating whether there is an association between HCV treatment response and SNPs of apoptosis-related genes during HIV/HCV coinfection
View PublicationRisk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV
Assessing risk factors for reinfection after sustained virologic response in a representative cohort of Canadian coinfected patients in clinical care
View PublicationHCV‐specific T cells in HCV/HIV co‐infection show elevated frequencies of dual Tim‐3/PD‐1 expression that correlate with liver disease progression
Investigating the role of programmed death‐1and T‐cell immunoglobulin and mucin domain‐containing molecule‐3 expression in T‐cell exhaustion during HCV/HIV co‐infection
View PublicationIs Antiretroviral Therapy Causing Long-Term Liver Damage? A Comparative Analysis of HIV-Mono-Infected and HIV/Hepatitis C Co-Infected Cohorts
Investigating the relationship between cumulative HAART exposure and hepatic fibrosis
View PublicationEvaluating Liver Fibrosis Progression and the Impact of Antiretroviral Therapy in HIV and Hepatitis C Coinfection Using a Noninvasive Marker
Evaluating the evolution of a noninvasive measure of liver fibrosis and determining its predictive value for hepatic outcomes in HIV-positive patients with and without HCV coinfection
View PublicationImmunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy
Evaluating immunogenicity, manufacturing feasibility, and safety of a novel, autologous dendritic cell-based immunotherapy
View PublicationUrinary symptoms and quality of life in women living with HIV: a cross-sectional study
Determining prevalence and quality of life impact of lower urinary tract symptoms in women living with HIV
View Publication